BLUEACRE TECHNOLOGY LIMITED

Their core work

Blueacre Technology is an Irish precision engineering SME specialising in microfabrication and laser micromachining of medical devices and implants. Their core competence is manufacturing at the intersection of advanced materials and medical applications — from producing custom fibre-reinforced composite surgical instruments via micro-pullwinding, to laser-machining titanium and nitinol implants for ophthalmic surgery. In EU projects they serve as the manufacturing partner who translates clinical or materials research into fabricated, testable devices. Their work spans the full arc from process engineering and statistical quality control through to clinical-grade device production.

What they specialise in

How they've shifted over time

In their first project (OPENMIND, 2015–2018), Blueacre worked on composite material manufacturing — fibre-reinforced plastics shaped by micro-pullwinding — combined with data mining and statistical process control to enable personalised surgical device production at varying lot sizes. By their second project (HUMANeye, 2019–2023), the materials and application domain had shifted entirely: composite processing gave way to precision laser micromachining of metals (titanium, nitinol), and the clinical context moved from general minimally invasive surgery to the highly specific domain of corneal shape correction and ophthalmic implants. The through-line is precision medical device fabrication, but the technology pivot from polymer composites to metallic laser processing suggests the company is following market demand toward harder-material, implantable-grade components.

Blueacre is moving deeper into metallic precision microfabrication for implantable medical devices, with ophthalmology emerging as a specific application domain — making them a relevant partner for any consortium needing laser machining of nitinol, titanium, or similar biocompatible metals.

How they like to work

Blueacre has participated in both its H2020 projects as a non-coordinating partner, indicating they prefer or are suited to a specialist contributor role rather than project leadership. With 11 distinct consortium partners across two projects, they have not concentrated their network around a single group, suggesting they are flexible in joining different consortia as a manufacturing expert. This profile — small SME, specialist skills, no coordination history — is typical of a company brought in for a specific technical task rather than for project management.

Blueacre has built a modest but geographically spread network of 11 unique partners across 5 countries through two projects. Their European reach and varied partners in both RIA and IA funding schemes indicate they are familiar with collaborative R&D and can work within multi-national consortia.

What sets them apart

Blueacre occupies a rare niche: a small Irish precision engineering company with demonstrated capability in both advanced polymer composite manufacturing and metallic laser micromachining, applied specifically to medical devices. Very few SMEs span both material classes at medical-grade precision, and their combination of fabrication skill with data-driven process control (statistical SPC, similarity algorithms) gives them credibility beyond pure prototyping. For consortium builders, they are the type of partner who can take a clinical concept and produce actual devices that go into animal or clinical trials.

Highlights from their portfolio

• OPENMIND
  The larger of the two projects (€600,295), combining composite microfabrication with AI-assisted process control to manufacture fully customised minimally invasive surgical devices on demand — an unusual fusion of advanced manufacturing and data science.
• HUMANeye
  Demonstrates a distinct pivot into ophthalmic implant territory, with Blueacre contributing laser micromachining of metallic materials (titanium, nitinol) for a device targeting keratoconus and corneal transplant alternatives, and including a clinical trial phase.